T. Rowe Price Associates’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-108,680
| Closed | -$30K | – | 3036 |
|
|
2022
Q3 | $30K | Sell |
108,680
-153,375
| -59% | -$67K | ﹤0.01% | 2889 |
|
|
2022
Q2 | $202K | Hold |
262,055
| – | – | ﹤0.01% | 2603 |
|
|
2022
Q1 | $280K | Hold |
262,055
| – | – | ﹤0.01% | 2576 |
|
|
2021
Q4 | $498K | Sell |
262,055
-10,100
| -4% | -$24.2K | ﹤0.01% | 2386 |
|
|
2021
Q3 | $819K | Hold |
272,155
| – | – | ﹤0.01% | 2145 |
|
|
2021
Q2 | $1.06M | Sell |
272,155
-2,446
| -0.9% | -$10.1K | ﹤0.01% | 2057 |
|
|
2021
Q1 | $1.39M | Buy |
274,601
+10,865
| +4% | +$56.4K | ﹤0.01% | 1882 |
|
|
2020
Q4 | $1.08M | Hold |
263,736
| – | – | ﹤0.01% | 1903 |
|
|
2020
Q3 | $1.28M | Hold |
263,736
| – | – | ﹤0.01% | 1700 |
|
|
2020
Q2 | $1.46M | Buy |
263,736
+1,681
| +0.6% | +$7.7K | ﹤0.01% | 1638 |
|
|
2020
Q1 | $860K | Hold |
262,055
| – | – | ﹤0.01% | 1766 |
|
|
2019
Q4 | $1.18M | Hold |
262,055
| – | – | ﹤0.01% | 1819 |
|
|
2019
Q3 | $1.09M | Hold |
262,055
| – | – | ﹤0.01% | 1787 |
|
|
2019
Q2 | $993K | Sell |
262,055
-46,945
| -15% | -$192K | ﹤0.01% | 1848 |
|
|
2019
Q1 | $1.29M | Sell |
309,000
-16,444
| -5% | -$57.5K | ﹤0.01% | 1738 |
|
|
2018
Q4 | $810K | Hold |
325,444
| – | – | ﹤0.01% | 1895 |
|
|
2018
Q3 | $2.38M | Sell |
325,444
-128,985
| -28% | -$565K | ﹤0.01% | 1576 |
|
|
2018
Q2 | $1.68M | Buy |
454,429
+264,448
| +139% | +$1.22M | ﹤0.01% | 1640 |
|
|
2018
Q1 | $731K | Hold |
189,981
| – | – | ﹤0.01% | 1920 |
|
|
2017
Q4 | $684K | Hold |
189,981
| – | – | ﹤0.01% | 1961 |
|
|
2017
Q3 | $750K | Hold |
189,981
| – | – | ﹤0.01% | 1910 |
|
|
2017
Q2 | $969K | Sell |
189,981
-35
| -0% | -$197 | ﹤0.01% | 1798 |
|
|
2017
Q1 | $1.31M | Hold |
190,016
| – | – | ﹤0.01% | 1700 |
|
|
2016
Q4 | $1.78M | Hold |
190,016
| – | – | ﹤0.01% | 1592 |
|
|
2016
Q3 | $1.86M | Buy |
190,016
+35
| +0% | +$472 | ﹤0.01% | 1553 |
|
|
2016
Q2 | $2.68M | Hold |
189,981
| – | – | ﹤0.01% | 1474 |
|
|
2016
Q1 | $2.66M | Hold |
189,981
| – | – | ﹤0.01% | 1476 |
|
|
2015
Q4 | $3.88M | Hold |
189,981
| – | – | ﹤0.01% | 1455 |
|
|
2015
Q3 | $2.5M | Hold |
189,981
| – | – | ﹤0.01% | 1523 |
|
|
2015
Q2 | $2.91M | Sell |
189,981
-18,254
| -9% | -$350K | ﹤0.01% | 1537 |
|
|
2015
Q1 | $4.16M | Sell |
208,235
-155,622
| -43% | -$3.48M | ﹤0.01% | 1496 |
|
|
2014
Q4 | $7.65M | Buy |
+363,857
| New | +$7.41M | ﹤0.01% | 1391 |
|
T. Rowe Price Associates's AGTC Position: Q4 2022 in Review
T. Rowe Price Associates sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 108,680 shares — an estimated $30K sold.
T. Rowe Price Associates first reported a position in AGTC in Q4 2014 and held it in 32 quarters. The position peaked at $7.65M in Q4 2014. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- T. Rowe Price Associates reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- T. Rowe Price Associates sold 108,680 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $30K.
- T. Rowe Price Associates first reported a position in Applied Genetic Technologies Corporation in Q4 2014 and held it in 32 quarters.
- T. Rowe Price Associates's Applied Genetic Technologies Corporation position peaked at $7.65M in Q4 2014.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.